Correlation Between China State and Jinhe Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China State and Jinhe Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China State and Jinhe Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China State Construction and Jinhe Biotechnology Co, you can compare the effects of market volatilities on China State and Jinhe Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China State with a short position of Jinhe Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of China State and Jinhe Biotechnology.

Diversification Opportunities for China State and Jinhe Biotechnology

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between China and Jinhe is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding China State Construction and Jinhe Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jinhe Biotechnology and China State is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China State Construction are associated (or correlated) with Jinhe Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jinhe Biotechnology has no effect on the direction of China State i.e., China State and Jinhe Biotechnology go up and down completely randomly.

Pair Corralation between China State and Jinhe Biotechnology

Assuming the 90 days trading horizon China State Construction is expected to generate 0.73 times more return on investment than Jinhe Biotechnology. However, China State Construction is 1.37 times less risky than Jinhe Biotechnology. It trades about 0.06 of its potential returns per unit of risk. Jinhe Biotechnology Co is currently generating about 0.01 per unit of risk. If you would invest  476.00  in China State Construction on September 3, 2024 and sell it today you would earn a total of  127.00  from holding China State Construction or generate 26.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

China State Construction  vs.  Jinhe Biotechnology Co

 Performance 
       Timeline  
China State Construction 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in China State Construction are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China State sustained solid returns over the last few months and may actually be approaching a breakup point.
Jinhe Biotechnology 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

China State and Jinhe Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China State and Jinhe Biotechnology

The main advantage of trading using opposite China State and Jinhe Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China State position performs unexpectedly, Jinhe Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jinhe Biotechnology will offset losses from the drop in Jinhe Biotechnology's long position.
The idea behind China State Construction and Jinhe Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing